Tower Research Capital LLC (Trc) Amneal Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,777 shares of AMRX stock, worth $13,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,777

Previous 803 121.3%

Holding current value

$13,736

Previous $6,000 133.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.69 - $9.25 $7,490 - $9,009	974 Added 121.3%	1,777 $14,000
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $171,966 - $236,520	-26,786 Reduced 97.09%	803 $6,000
Q2 2024 Aug 13, 2024	BUY	$5.36 - $7.11 $132,236 - $175,410	24,671 Added 845.48%	27,589 $175,000
Q1 2024 May 15, 2024	SELL	$5.24 - $6.34 $165,143 - $199,811	-31,516 Reduced 91.53%	2,918 $17,000
Q4 2023 Feb 13, 2024	BUY	$3.36 - $6.21 $100,044 - $184,902	29,775 Added 639.09%	34,434 $209,000
Q3 2023 Nov 14, 2023	SELL	$2.76 - $4.59 $17,956 - $29,862	-6,506 Reduced 58.27%	4,659 $19,000
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $8,098 - $18,875	6,089 Added 119.96%	11,165 $34,000
Q1 2023 May 09, 2023	SELL	$1.27 - $2.7 $4,271 - $9,080	-3,363 Reduced 39.85%	5,076 $7,000
Q4 2022 Feb 10, 2023	BUY	$1.96 - $2.61 $2,110 - $2,810	1,077 Added 14.63%	8,439 $17,000
Q3 2022 Nov 10, 2022	BUY	$2.02 - $3.62 $977 - $1,752	484 Added 7.04%	7,362 $15,000
Q2 2022 Aug 15, 2022	BUY	$3.01 - $4.46 $13,632 - $20,199	4,529 Added 192.81%	6,878 $22,000
Q1 2022 May 12, 2022	SELL	$3.9 - $4.89 $1,072 - $1,344	-275 Reduced 10.48%	2,349 $9,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $29,589 - $43,822	-7,491 Reduced 74.06%	2,624 $13,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $21,670 - $28,357	-5,028 Reduced 33.2%	10,115 $54,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $26,542 - $35,354	5,184 Added 52.05%	15,143 $78,000
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $155,050 - $241,407	-32,711 Reduced 76.66%	9,959 $67,000
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $381,814 - $523,908	-96,662 Reduced 69.38%	42,670 $195,000
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $368,878 - $549,149	104,203 Added 296.63%	139,332 $540,000
Q2 2020 Aug 13, 2020	BUY	$2.87 - $5.46 $100,820 - $191,804	35,129 New	35,129 $167,000
Q4 2019 Feb 07, 2020	SELL	$2.65 - $5.56 $14,344 - $30,096	-5,413 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$2.29 - $7.1 $5,388 - $16,706	-2,353 Reduced 30.3%	5,413 $16,000
Q2 2019 Aug 13, 2019	BUY	$6.44 - $14.29 $44,397 - $98,515	6,894 Added 790.6%	7,766 $56,000
Q1 2019 May 14, 2019	SELL	$11.87 - $14.84 $9,828 - $12,287	-828 Reduced 48.71%	872 $12,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $22,253 - $36,533	1,700 New	1,700 $23,000

Others Institutions Holding AMRX

# of Institutions

204

Shares Held

121M

Call Options Held

121K

Put Options Held

84.6K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.17B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Amneal Pharmaceuticals, Inc. Transaction History